Current Status of Intestinal Failure and Intestinal Transplantation.
10.5223/pghn.2012.15.3.127
- Author:
Jae Sung KO
1
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. kojs@snu.ac.kr
- Publication Type:Review
- Keywords:
Intestinal failure;
Short bowel syndrome;
Intestinal transplantation;
Child;
Survival
- MeSH:
Child;
Cytomegalovirus;
Emulsions;
Herpesvirus 4, Human;
Humans;
Immunosuppression;
Infection Control;
Rejection (Psychology);
Short Bowel Syndrome;
Transplants
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2012;15(3):127-137
- CountryRepublic of Korea
- Language:English
-
Abstract:
Pediatric intestinal failure occurs secondary to short bowel syndrome, motility disorders, or malabsorption. The establishment of an intestinal rehabilitation program and the introduction of innovative surgical and medical treatments, such as the serial transverse enteroplasty procedure and omega-3-containing lipid emulsions, have been major advances in the treatment of intestinal failure. Intestinal transplantation is now established as a therapeutic modality in selected children with irreversible intestinal failure. The improved short to intermediate term survival of intestinal transplant recipients in the last decade can be attributed to immunosuppression with a lymphocyte-depleting agent, control of acute cellular rejection, and comprehensive infection control with careful monitoring of viral pathogens including cytomegalovirus and Epstein-Barr virus.
